The TE Air is reportedly the first handheld ultrasound device to offer dual connectivity to mobile devices or touch-based ultrasound systems.
Offering the promise of enhanced connectivity and dedicated presets for a variety of clinical exams, Mindray has launched TE Air, a wireless handheld ultrasound modality.
Mindray said the TE Air offers enhanced utility and accessibility, claiming that the device is the first handheld ultrasound that can be connected to mobile devices or the touch-based TE X Ultrasound System.
“The TE Air is a leap forward in ultrasound technology, offering comprehensive functionality inside or outside the hospital environment,” noted Wayne Quinn, the president of Mindray North America. “The new 2-in-1 innovative solution empowers clinicians to overcome the traditional constraints of cords and confined spaces, giving them access to premium scanning capability when and where they need it.”
The company noted a number of additional features with TE Air including:
• a phased array with exam presets for a variety of clinical exams including cardiac exams, transcranial imaging, lung imaging and OB/GYN exams;
• single crystal technology that facilitates high-resolution imaging quality; and
• a waterproof design that allows for easy cleaning of the device with compatible disinfectant products.
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.